cdmo.directory
← Compare landing

ProBioGen AG vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/probiogen/ubrigene

CategoryProBioGen AGuBriGene
Listed sitecdmoboth
SummaryProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Oncology
Locations
  • Headquarters, Berlin, Berlin, Germany
  • Office, Berlin, Berlin, Germany
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
Certifications
  • EMA · Identifier: GMP compliant
  • FDA · Identifier: GMP compliant
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.